KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Holders of 5% or more of KALA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of KALA BIO, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13D/A | 19.70%1.20M shares | – | Dec 31, 20241 filing | Dec 31, 2024 | SEC |
| Oxford Finance LLC | 13G | 16.50%1.62M shares | New | Dec 3, 20251 filing | Dec 3, 2025 | SEC |
| Cormorant Asset Management, LP | 13G | 9.99%609.0K shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Perceptive Advisors LLC | 13G | 7.70%543.7K shares | New | Sep 11, 20251 filing | Sep 11, 2025 | SEC |
| Point72 Asset Management, L.P. | 13G | 6.70%469.2K shares | New | Sep 11, 20251 filing | Sep 11, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on KALA BIO, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 3, 20254:51 PM ET | Oxford Finance LLC | 13G | 16.50%1.62M shares | New | Nov 25, 2025 | SEC |
| Sep 11, 20255:28 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 6.70%469.2K shares | New | Sep 4, 2025 | SEC |
| Sep 11, 20254:02 PM ET | Perceptive Advisors LLCand 2 others | 13G | 7.70%543.7K shares | New | Sep 4, 2025 | SEC |
| May 12, 20254:00 PM ET | Millennium Management LLCand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20259:04 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 4.91%299.0K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20253:01 PM ET | Cormorant Asset Management, LPand 1 other | 13G | 9.99%609.0K shares | New | Dec 31, 2024 | SEC |
| Dec 31, 20244:18 PM ET | Baker Bros. Advisors LPand 3 others | 13D/A | 19.70%1.20M shares | – | Dec 29, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell KALA BIO, Inc. shares.
No Form 144 notices for KALA BIO, Inc. are on file.